Published in J Neural Transm (Vienna) on December 13, 2012
A common immunopathogenesis mechanism for infectious diseases: the protein-homeostasis-system hypothesis. Infect Chemother (2015) 0.87
Controversies in neurology, Vienna, 2012: steroids in bacterial meningitis: no. J Neural Transm (Vienna) (2012) 0.80
Open craniotomy for brain abscess: A forgotten experience? Surg Neurol Int (2013) 0.78
The role of adjunctive dexamethasone in the treatment of bacterial meningitis: an updated systematic meta-analysis. Patient Prefer Adherence (2016) 0.75
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet (2012) 25.96
Dexamethasone in adults with bacterial meningitis. N Engl J Med (2002) 11.10
Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med (2004) 7.87
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev (2000) 4.59
Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet (2002) 4.57
CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol (2007) 4.00
Treatment of bacterial meningitis. N Engl J Med (1997) 3.07
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med (1990) 2.89
Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol (2006) 2.67
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet (2005) 2.49
Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci (1999) 2.43
Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA (1997) 2.29
Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis (2002) 2.05
Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis (1989) 1.66
Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis (2002) 1.64
Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol (1999) 1.38
The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine (2006) 1.30
Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. Eur J Neurol (2007) 1.22
Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis (1992) 1.20
Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun (1996) 1.19
Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol (2007) 1.09
New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis (2010) 1.08
Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology (1999) 1.04
Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev (2010) 1.04
ACTH and adrenal steroids in the treatment of pneumococcal meningitis in adults. Am J Med (1958) 0.91
Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J Antimicrob Chemother (2003) 0.90
Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis. Clin Infect Dis (2009) 0.83
Modulation of brain injury as a target of adjunctive therapy in bacterial meningitis. Curr Infect Dis Rep (2010) 0.81
Pneumococcal meningitis: a 21st century perspective. Lancet Neurol (2006) 0.75
Pneumococcal meningitis treated with hydrocortisone, ACTH, and antibiotics. Med Bull (Ann Arbor) (1956) 0.75
The treatment of purulent meningitis with adrenal cortico-steroids. Singapore Med J (1962) 0.75
Long-term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis. Scand J Infect Dis (2006) 0.75
Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol (2005) 3.34
Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol (2007) 2.42
Neurological picture. Herpes zoster duplex bilateralis. J Neurol Neurosurg Psychiatry (2007) 1.79
Synchronized infection of cell cultures by magnetically controlled virus. J Virol (2005) 1.14
Past as prologue: delayed stroke as a parainfectious process of bacterial meningitis? Neurology (2009) 1.13
Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia. Brain Pathol (2007) 1.11
Recent issues in herpes simplex encephalitis. J Neurovirol (2013) 1.08
Creutzfeldt-Jakob disease. JAMA Neurol (2013) 1.06
Infectious causes of multiple sclerosis. Lancet Neurol (2006) 1.04
Chronic intracranial hypertension with unexplained cerebrospinal fluid pleocytosis. J Neuroophthalmol (2004) 0.97
Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol (2004) 0.96
Acute bilateral paramedian thalamic infarcts after occlusion of the artery of Percheron. Neurology (2006) 0.94
Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures. J Virol (2007) 0.93
Neurological abnormalities associated with celiac disease. J Neurol (2004) 0.93
The multiple sclerosis severity score (MSSS) predicts disease severity over time. J Neurol Sci (2009) 0.92
Neurotropism of herpes simplex virus type 1 in brain organ cultures. J Gen Virol (2006) 0.92
The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. J Neurovirol (2002) 0.91
Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletion. Am J Med Genet (2002) 0.90
Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis? Neurology (2010) 0.88
Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. Med Hypotheses (2005) 0.85
Myasthenia gravis in the elderly. J Neurol Sci (2012) 0.83
Primary brain T-cell lymphoma in an HTLV-1 serologically positive male. J Neurol Sci (2011) 0.83
Restrictions that control herpes simplex virus type 1 infection in mouse brain ex vivo. J Gen Virol (2011) 0.83
Treating post Lyme disease: trying to solve one equation with too many unknowns. Neurology (2003) 0.82
Patient and caregiver perceptions of the social impact of advanced Parkinson's disease and dyskinesias. J Neural Transm (Vienna) (2012) 0.81
PML: underdiagnosed in MS patients on natalizumab. Lancet Neurol (2010) 0.81
Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity. J Mol Neurosci (2013) 0.80
Involvement of cellular death signals in the reactivation of herpes simplex virus type 1 and lambda bacteriophage from a latent state. J Theor Biol (2005) 0.80
Transgenic mouse with the herpes simplex virus type 1 latency-associated gene: expression and function of the transgene. J Virol (2003) 0.80
Nonconvulsive status epilepticus in older people: a diagnostic challenge and a treatable condition. J Am Geriatr Soc (2007) 0.79
Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients. J Neurol (2008) 0.79
Plagiarism. Trans R Soc Trop Med Hyg (2010) 0.78
Post infectious CNS disorders: towards a unified approach. J Neurol (2010) 0.78
The protective effect of risk factors against stroke severity. J Neurol Sci (2008) 0.78
Nocturnal carbon dioxide monitoring in patients with idiopathic intracranial hypertension. Clin Neurol Neurosurg (2013) 0.77
On human disease and animal models. Ann Neurol (2011) 0.77
The possible risk for strokes complicating cardiac surgery in patients with intraoperative hypothermia. Cerebrovasc Dis (2010) 0.76
Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditions. Int Clin Psychopharmacol (2016) 0.76
Different modes of herpes simplex virus type 1 spread in brain and skin tissues. J Neurovirol (2014) 0.76
The "one virus, one disease" model of multiple sclerosis is too constraining. Ann Neurol (2007) 0.75
Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology (2007) 0.75
The occurrence of Guillain-Barré syndrome within families. Neurology (2005) 0.75
Smoking is a risk factor for multiple sclerosis. Neurology (2004) 0.75
Coital headaches induced by amiodarone. Neurology (2002) 0.75
Quantitative risk-benefit analysis of natalizumab. Neurology (2009) 0.75
Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology (2002) 0.75
Quo vadis multiple sclerosis? Inflammopharmacology (2010) 0.75
Re: Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology (2008) 0.75
Herpes zoster duplex bilateralis. BMJ Case Rep (2009) 0.75
Neurological deficits in patients with celiac disease. Arch Neurol (2002) 0.75
Lack of migraine in headaches of familial dysautonomia patients. J Neural Transm (Vienna) (2012) 0.75
Complete mitochondrial DNA sequence analysis in a family with early-onset dystonia and optic atrophy. Mov Disord (2004) 0.75
Unusual and benign course of idiopathic facial diplegia. J Clin Neurosci (2013) 0.75
Acute confusion and seizures in a 63-year-old woman. J Clin Neurosci (2013) 0.75
A 66-year-old patient with progressive left hemiparesis: question. J Clin Neurosci (2014) 0.75
The relatively good outcome of cerebellum-brainstem ischemic strokes. Eur Neurol (2012) 0.75